Biovie
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -57 | -57 | -57 | -57 |
EBITDA | -5,206 | -6,006 | -5,071 | -3,426 |
EBIT | -5,264 | -6,063 | -5,129 | -3,484 |
Net Income | -5,270 | -6,069 | -5,087 | -3,489 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,441 | -4,437 | -3,023 | -5,607 |
Cash | 13,098 | 20,540 | 24,978 | 17,544 |
Basic Shares | 7,543 | 7,920 | 5,214 | 14,773 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -229 | -229 | -266 | -237 |
EBITDA | -16,980 | -28,997 | -45,726 | -23,692 |
EBIT | -17,209 | -29,226 | -45,955 | -23,921 |
Net Income | -17,542 | -32,120 | -50,255 | -26,084 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 14,130 | |||
Free Cash Flow | -19,025 | -27,945 | -40,252 | -18,990 |
Cash | 17,544 | 23,843 | 19,460 | 18,641 |
Basic Shares | 1,477 | 451 | 324 | 246 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.69 |
2025-12-31 | -$0.76 |
2025-09-30 | -$0.98 |
2025-06-30 | -$11.05 |